Astellas Pharma News and Activities

Presence

Astellas Pharma develops, manufactures, and sells prescription medicines. Its main products include treatments for cancer, urology, immunology, and rare diseases for hospitals, clinics, and patients worldwide.

Astellas Pharma products and services overview:

Oncology drugs
Urology treatments
Immunology medicines
Rare disease therapies
Transplant medicines
Infectious disease drugs

Revenue: ~$13 billion

Employees: 14,500

Headquarters: Tokyo, Japan

Astellas Pharma is one of the...

Astellas Pharma is a company listed under the stock ticker 4503 (JP).

Astellas Pharma has a direct presence in 11 countries.

Astellas Pharma has 11 subsidiaries including Astellas Farma Brasil, Astellas Netherlands and Astellas Pharma Belgium.

They are in:

Pharmaceuticals92%
Biotechnology8%

Executives

View the org chart displaying its 76 main executives

Most searched biographies at Astellas Pharma

Popular executive movements at Astellas Pharma

Peter Sandor who was Head of Corporate Strategy, becomes Interim Chief Strategy Officer (posted on April 3 2026).
Adam Pearson, Chief Strategy Officer, is retiring (posted on April 3 2026).
Anjana Harve has joined the company as Chief Digital Officer (posted on January 28 2026).

Click here to view some more movements at Astellas Pharma

Create your alert
to follow the executive moves at Astellas Pharma.